{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:05:49Z","timestamp":1794413149469,"version":"4.9.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186619","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T14:09:51Z","timestamp":1508422191000},"page":"e0186619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-0175","authenticated-orcid":true,"given":"Andargachew","family":"Mulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Gerd","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","article-title":"Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting","volume":"9","author":"JS Montaner","year":"2014","journal-title":"PLoS ONE"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1744-8603-10-43","article-title":"Scaling up antiretroviral treatment and improving patient retention in care: Lessons from Ethiopia, 2005\u20132013","volume":"10","author":"Y Assefa","year":"2014","journal-title":"Global Health"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-14-28","article-title":"Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children","volume":"14","author":"A Mulu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e0141318","DOI":"10.1371\/journal.pone.0141318","article-title":"Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study","volume":"10","author":"A Mulu","year":"2015","journal-title":"PLoS ONE"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0b013e32835b7f94","article-title":"Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa","volume":"8","author":"RL Hamers","year":"2013","journal-title":"Current Opinion in HIV and AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jmv.24110","article-title":"Limited increase in primary HIV-1C drug resistance mutations in treatment naive individuals in Ethiopia","volume":"87","author":"K Huruy","year":"2015","journal-title":"J Med Virol"},{"key":"ref7","article-title":"Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa","author":"TS Boender","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/cit627","article-title":"Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving Highly Antiretroviral Therapy and Monitored With the World Health Organization Public Health Approach in Sub-Saharan Africa and Southeast Asia","volume":"58","author":"AF Aghokeng","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(09)70328-7","article-title":"Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: A systematic review","volume":"10","author":"RE Barth","year":"2010","journal-title":"The Lancet Infectious Diseases"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: A multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"The Lancet Infectious Diseases"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jac\/dkw051","article-title":"HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults","volume":"71","author":"C Hawkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref12","first-page":"3","article-title":"Update on HIV-1 acquired and transmitted drug resistance in Africa","volume":"17","author":"D Ssemwanga","year":"2015","journal-title":"AIDS Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/QAI.0000000000000753","article-title":"Brief Report: Long-term Outcomes and Their Determinants in Patients on Antiretroviral Treatment in Ethiopia, 2005\/6-2011\/12: A Retrospective Cohort Study","volume":"70","author":"Y Assefa","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2334-14-158","article-title":"Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia","volume":"14","author":"A Mulu","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"ref15","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/cid\/cis206","article-title":"Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004\u20132011","volume":"54","author":"MR Jordan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e110749","DOI":"10.1371\/journal.pone.0110749","article-title":"Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients","volume":"9","author":"LM Hofstra","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"ref17","first-page":"132","article-title":"2017Update of the Drug Resistance Mutations in HIV-1","volume":"24","author":"AM Wensing","year":"2017","journal-title":"Top Antivir Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis","volume":"380","author":"RK Gupta","year":"2012","journal-title":"The Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-11-9","article-title":"HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study","volume":"11","author":"AS Hassan","year":"2014","journal-title":"AIDS Res Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0145772","DOI":"10.1371\/journal.pone.0145772","article-title":"HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing","volume":"10","author":"S Rhee","year":"2015","journal-title":"PLoS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis","volume":"12","author":"S Rhee","year":"2015","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/hiv.12236","article-title":"Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial","volume":"16","author":"JD Baxter","year":"2015","journal-title":"HIV Med"},{"key":"ref23","first-page":"183","article-title":"Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia","volume":"7","author":"K Demissie","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"ref24","first-page":"119","article-title":"Consistent condom use in HIV\/AIDS patients receiving antiretroviral therapy in northwestern Ethiopia: implication to reduce transmission and multiple infections","volume":"7","author":"Z Shewamene","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e0140835","DOI":"10.1371\/journal.pone.0140835","article-title":"HIV Prevalence Correlates with High-Risk Sexual Behavior in Ethiopia's Regions","volume":"10","author":"CR Kenyon","year":"2015","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study","volume":"16","year":"2016","journal-title":"The Lancet Infectious Diseases"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(10)61487-0","article-title":"Nurse management of HIV-infected patients","volume":"376","author":"Y Assefa","year":"2010","journal-title":"The Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(10)60894-X","article-title":"Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): A randomized non-inferiority trial","volume":"376","author":"I Sanne","year":"2010","journal-title":"The Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/v6104095","article-title":"Current Perspectives on HIV-1 Antiretroviral Drug Resistance","volume":"6","author":"P Iyidogan","year":"2014","journal-title":"Viruses"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/v8020048","article-title":"Genetic Variability of HIV-1 for Drug Resistance Assay Development","volume":"8","author":"D Clutter","year":"2016","journal-title":"Viruses"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:31:38Z","timestamp":1540341098000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186619"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186619","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.g003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.g004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.g005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0186619.s002","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}